搜索结果: 1-6 共查到“医学 erythropoietin”相关记录6条 . 查询时间(0.072 秒)
Rapid hemodilution induced by desmopressin after erythropoietin administration in humans
HEMOGLOBIN HEMATOCRIT RETICULOCYTES STIMULATION INDEX PLASMA VOLUME EXPANDERS
2013/10/4
We have shown that treatment with desmopressin has a very effective hemodilution effect in healthy humans. These results led us to suggest the possible role of desmopressin to mask blood doping in spo...
Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
Anemia Prematurity Recombinant erythropoietin Newborn
2015/9/25
Background: Premature neonates are at risk for severe anemia and erythropoietin is the most important hormone in erythropoiesis. The aim of this study was to evaluate the influence of oral recombinant...
The Effect of Erythropoietin in Acute Pancreatitis:An Experimental Study
Department of Surgery,Ankara Numune Teaching and Research Hospital,Ankara-TURKEY Department of Pathology,Ankara Numune Teaching and Research Hospital,Ankara-TURKEY
2009/6/19
Background: Although the pathogenesis of acute pancreatitis is not clearly known, the most frequently mentioned factors are proinflammatory cytokines and nitric oxide (NO), which is stimulated by bact...
The Effect of Erythropoietin on Neurotrophic Factors in N9 Murine Microglial Cells
Microglia N9 cell line murine erythropoietin neurotrophic factors
2009/6/16
Aim: In this study, we investigated whether interferon gamma (IFNg), lipopolysaccharides (LPS) and amyloid beta (AMYb), as toxic stimulator agents, and erythropoietin (EPO), as a neurotrophic agent, h...
The Effect of Human Recombinant Erythropoietin on Prevention of Anemia of Prematurity
Neonate Anemia Prematurity Erythropoietin Anemia prevention
2010/4/20
Objective: Premature infants often develop significant anemia that requires blood transfusion, this carries significant risks. This study was carried out to determine the effect of recombinant human e...
Eraly Treatment of Anemia of Prematurity with Recombinant Human Erythropoietin
anemia of prematurely erythropoietin treatment
2015/9/7
Background: Recombinant Human Erythropoietin (EPO) is known to accelerate erythropoesis in preterm infants. This study was designed to access of EPO in treatment of anemia of prematurity.
Materials a...